DK0559795T3 - Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen - Google Patents

Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen

Info

Publication number
DK0559795T3
DK0559795T3 DK92901813.3T DK92901813T DK0559795T3 DK 0559795 T3 DK0559795 T3 DK 0559795T3 DK 92901813 T DK92901813 T DK 92901813T DK 0559795 T3 DK0559795 T3 DK 0559795T3
Authority
DK
Denmark
Prior art keywords
methods
peripheral nerve
nerve damage
chronic pain
cervical spine
Prior art date
Application number
DK92901813.3T
Other languages
Danish (da)
English (en)
Inventor
Bruce M Cameron Sr
Carl R Merril
Guy Joseph Creed
Dale Vanderputten
Original Assignee
Monoclonetics Int
Us Health
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Monoclonetics Int, Us Health filed Critical Monoclonetics Int
Application granted granted Critical
Publication of DK0559795T3 publication Critical patent/DK0559795T3/da

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
    • G01N33/561—Immunoelectrophoresis
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/10—Musculoskeletal or connective tissue disorders
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2842—Pain, e.g. neuropathic pain, psychogenic pain

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Organic Chemistry (AREA)
  • Electrochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Neurosurgery (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
DK92901813.3T 1990-11-30 1991-11-15 Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen DK0559795T3 (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US62010490A 1990-11-30 1990-11-30

Publications (1)

Publication Number Publication Date
DK0559795T3 true DK0559795T3 (da) 1996-01-29

Family

ID=24484596

Family Applications (1)

Application Number Title Priority Date Filing Date
DK92901813.3T DK0559795T3 (da) 1990-11-30 1991-11-15 Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen

Country Status (11)

Country Link
US (2) US5364793A (ja)
EP (1) EP0559795B1 (ja)
JP (1) JPH06503418A (ja)
AT (1) ATE132269T1 (ja)
AU (1) AU667462B2 (ja)
CA (1) CA2097426A1 (ja)
DE (1) DE69115926T2 (ja)
DK (1) DK0559795T3 (ja)
ES (1) ES2083152T3 (ja)
GR (1) GR3018546T3 (ja)
WO (1) WO1992010760A1 (ja)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK145393D0 (da) * 1993-12-23 1993-12-23 Stig Haunsoe Proteinmarkoerer til forudsigelse af akut allotransplantatafstoedning
GB9509410D0 (en) * 1995-05-10 1995-07-05 Imperial College Molecular imaging
DE19548221C1 (de) * 1995-12-22 1997-05-15 Biotest Pharma Gmbh Orale Anwendung von Immunglobulin-Präparationen zur Behandlung und Prophylaxe chronischer Schmerzzustände
US6048691A (en) * 1996-05-13 2000-04-11 Motorola, Inc. Method and system for performing a binding assay
AUPO403496A0 (en) * 1996-12-05 1997-01-02 Macquarie Research Limited Electrophoresis separation methods
US5908383A (en) * 1997-09-17 1999-06-01 Brynjestad; Ulf Knowledge-based expert interactive system for pain
US6251587B1 (en) 1997-12-16 2001-06-26 Nova Molecular, Inc. Method for determining the prognosis of a patient with a neurological disease
GB9812290D0 (en) * 1998-06-09 1998-08-05 Univ Nottingham Back pain diagnosis
CA2351877C (en) 1998-11-23 2012-01-24 Proteome Sciences, Inc. Methods and compositions for pain management
WO2000070340A2 (en) * 1999-05-14 2000-11-23 Karolinska Innovations Ab Materials and methods relating to disease diagnosis
US6231525B1 (en) 1999-10-25 2001-05-15 William C. Paske System and method for providing quantified hand analysis
US6264621B1 (en) 1999-10-29 2001-07-24 William C. Paske System and method for providing quantified and qualitative hand analysis
ES2252263T3 (es) * 2000-07-25 2006-05-16 The Government Of The Usa, As Represented By The Secretary, Department Of Health And Human Services Bacteriofago que tiene una gama de hospedadores multiple.
US7179609B1 (en) 2000-10-04 2007-02-20 Atrophus Ab Screening method for gastritis
US20030113808A1 (en) * 2001-12-13 2003-06-19 George Jackowski Apolipoprotein biopolymer markers predictive of alzheimers disease
US20040097838A1 (en) * 2002-11-19 2004-05-20 Paske William C. System and apparatus for providing quantified hand analysis
US20040215074A1 (en) * 2003-04-24 2004-10-28 Vincenzo Giuliano Imaging and scoring method for cervical spinal impairment using magnetic resonance imaging
US7846094B2 (en) * 2004-03-17 2010-12-07 Miller Landon C G System and method for neurological injury detection, classification and subsequent injury amelioration
JP5537775B2 (ja) * 2005-01-28 2014-07-02 ザ リージェンツ オブ ザ ユニヴァーシティ オブ カリフォルニア 細胞組織の痛み及び変性特性を評価するために核磁気共鳴（ｎｍｒ）分光を用いるシステム及び方法
US20080015465A1 (en) * 2006-06-15 2008-01-17 Scuderi Gaetano J Methods for diagnosing and treating pain in the spinal cord
US7709215B2 (en) * 2007-06-01 2010-05-04 Cytonics Corporation Method for diagnosing and treating acute joint injury
US8761860B2 (en) 2009-10-14 2014-06-24 Nocimed, Llc MR spectroscopy system and method for diagnosing painful and non-painful intervertebral discs
US8825131B2 (en) 2009-10-14 2014-09-02 Nocimed, Llc MR spectroscopy system and method for diagnosing painful and non-painful intervertebral discs
US9280718B2 (en) 2010-11-24 2016-03-08 Nocimed, Llc Systems and methods for automated voxelation of regions of interest for magnetic resonance spectroscopy
US11305023B2 (en) 2011-11-11 2022-04-19 Sam Popinchalk Method for diagnostically imaging lesions in the peripheral nervous system
US8965094B2 (en) 2012-04-14 2015-02-24 Nocimed, Llc Magnetic resonance spectroscopy pulse sequence, acquisition, and processing system and method
WO2017120298A1 (en) * 2016-01-05 2017-07-13 University Of Rochester Treatment of radiculopathies with 4-aminopyridine or derivatives thereof
EP4289347A3 (en) 2016-06-19 2024-03-06 Aclarion, Inc. Magnetic resonance spectroscopy system and method for diagnosing pain or infection associated with propionic acid
KR20210014109A (ko) * 2018-05-10 2021-02-08 더 메서디스트 하스피틀 질환의 예후와 관리 방법

Family Cites Families (69)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1598807A1 (de) * 1966-07-16 1971-01-07 Merck Patent Gmbh Verfahren und Mittel zur Fruehdiagnose der Phenylketonurie,der Ahornsirupkrankheit und der Hypervalinaemie
AT320865B (de) * 1973-02-12 1975-03-10 Immuno Ag Verfahren zum Bestimmen von normalen und pathologischen Plasma-Lipoproteinen in menschlichen Körperflüssigkeiten und Apparat zur Durchführung des Verfahrens
US3979507A (en) * 1973-11-23 1976-09-07 Wilson Pharmaceutical & Chemical Corporation Diagnostic system for organ abnormalities
DE2406959C3 (de) * 1974-02-14 1979-02-08 Behringwerke Ag, 3550 Marburg Anordnung und Verfahren zur Bestimmung von Antigenen
US4124470A (en) * 1974-04-30 1978-11-07 Harald Dahms Method and apparatus for electrophoresis
US4118469A (en) * 1976-04-27 1978-10-03 Research Corporation Antigen for trachoma lymphogranuloma venereum (LGV) and non-gonococcal urethritis (NGU)
NL7701800A (nl) * 1977-02-18 1978-08-22 Akzo Nv Testkit en methode voor de bepaling van lp-x.
CA1121290A (en) * 1978-02-14 1982-04-06 Yasuji Suhara Amino sugar derivatives
DE2829531A1 (de) * 1978-07-05 1980-01-24 Heuck Claus Christian Dr Rer N Verfahren zur quantitativen bestimmung eines serumproteins in getruebten serum- und plasma-proben
US4264589A (en) * 1978-12-20 1981-04-28 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
US4178285A (en) * 1978-12-20 1979-12-11 Felts James M Separation of active α1 -acid glycoprotein and utilization in the lipoprotein lipase enzyme system
JPS5668695A (en) * 1979-11-10 1981-06-09 Sankyo Co Ltd Enzyme inhibitor griseolic acid and its preparation
US4416998A (en) * 1981-04-02 1983-11-22 The Upjohn Company Silver stain procedure and kit for same
US4822776A (en) * 1981-09-08 1989-04-18 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
US4603106A (en) * 1982-02-22 1986-07-29 The Rockefeller University Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
EP0174478B1 (de) * 1981-09-10 1991-12-11 B. Braun Holding AG Verfahren zur selektiven extrakorporalen Präzipitation von Low Density Lipoproteinen aus Vollserum oder Plasma
JPS58134992A (ja) * 1982-01-21 1983-08-11 Kitasato Inst:The 抗生物質ａｍ−２６０４−ａおよびその製造方法
US4468466A (en) * 1982-02-16 1984-08-28 The United States Of America As Represented By The Department Of Health And Human Services Silver stains for protein in gels--a modified procedure
GR79202B (ja) * 1982-05-05 1984-10-22 Genentech Inc
FR2533704B1 (fr) * 1982-09-27 1986-03-21 Spiral Dosage immunologique dans le serum de l'apolipoproteine b des lipoproteines de basse densite
US4466951A (en) * 1982-11-12 1984-08-21 University Of California Intracellular trapping of therapeutics or tracer agents
DE3310727A1 (de) * 1983-03-24 1984-10-04 B. Braun Melsungen Ag, 3508 Melsungen Verfahren und vorrichtung zur selektiven, extrakorporalen abtrennung pathologischer und/oder toxischer blutbestandteile
US4558007A (en) * 1983-06-17 1985-12-10 Health Research, Inc. (Roswell Park Divison) Process for detecting LDHk isozyme activity in human serum for use as a diagnostic aid and for monitoring response to cancer therapy
US4654301A (en) * 1983-06-17 1987-03-31 Health Research, Inc. (Roswell Park Division) Process for detecting LDHk isozyme activity in human serum for use as a diagnostic aid and for monitoring response to cancer therapy
DE3323949A1 (de) * 1983-07-02 1985-01-03 Boehringer Mannheim Gmbh, 6800 Mannheim Verfahren und mittel zur raschen und vollstaendigen beseitigung einer truebung in einer biologischen fluessigkeit
JPS6015559A (ja) * 1983-07-06 1985-01-26 Shiraimatsu Shinyaku Kk アポリポ蛋白−ｂの酵素免疫測定試薬
BG49718A3 (en) * 1983-07-15 1992-01-15 Bio Technology General Corp Method for preparing of polypeptid with superoxiddismutasne activitty
DE3330770A1 (de) * 1983-08-26 1985-03-14 Behringwerke Ag, 3550 Marburg Verfahren zur pasteurisierung von humanplasma
SE8304836D0 (sv) * 1983-09-09 1983-09-09 Pharmacia Ab Sett att bestemma forendringar i ledbrosk
EP0162054B1 (en) * 1983-09-30 1991-03-06 Massachusetts Institute Of Technology Production of cdna representing hepatitis a viral sequences
DE3338836A1 (de) * 1983-10-26 1985-05-09 Boehringer Mannheim Gmbh Verfahren zur bestimmung der low density lipoproteine (ldl) und reagenz zu seiner durchfuehrung
FR2560996B1 (fr) * 1984-03-09 1988-01-15 Commissariat Energie Atomique Procede de dosage immunologique d'antigenes, d'anticorps ou d'haptenes, son utilisation pour le dosage des lipoproteines et de l'a-foetoproteine et trousses de dosage pour la mise en oeuvre de ce procede
US4619895A (en) * 1984-05-10 1986-10-28 The Regents Of The University Of California Lipoprotein marker for hypertriglyceridemia
DE3582532D1 (de) * 1984-06-13 1991-05-23 Ares Serond Research & Dev Ltd Vorrichtungen zur verwendung in chemischen analyseverfahren.
JPH06105257B2 (ja) * 1984-08-07 1994-12-21 協和メデックス株式会社 癌の測定用キット
US4970144A (en) * 1984-12-31 1990-11-13 International Genetic Engineering Peptide fragments of human apolipoprotein, type-specific antibodies and methods of use
US4645748A (en) * 1985-02-01 1987-02-24 Charles Hurwitz Protein which is characteristic of rheumatoid arthritis
JPH065227B2 (ja) * 1985-02-27 1994-01-19 オリンパス光学工業株式会社 電気泳動装置による総蛋白値の定量方法
US4677057A (en) * 1985-03-11 1987-06-30 Scripps Clinic And Research Foundation Diagnostic assay for the presence of apolipoproteins associated with plasma high density lipoproteins
US4820505A (en) * 1985-04-04 1989-04-11 Scripps Clinic And Research Foundation Detection of activated platelets with antibodies to thrombospondin
US4895558A (en) * 1985-07-15 1990-01-23 University Of Queensland Autologous plasma delipidation using a continuous flow system
EP0213099A3 (de) * 1985-08-23 1989-07-19 Cederroth Nordic Aktiebolag Mittel mit antiphlogistischer, immunstimulierender und zytoprotektiver Wirkung, ihre Herstellung und pharmazeutische Verwendungen
SE448324B (sv) * 1985-09-27 1987-02-09 Pharmacia Ab Sett vid immunkemisk bestemning av lipoproteiner och apolipoproteiner
US4772549A (en) * 1986-05-30 1988-09-20 Biotechnology Research Partners, Ltd. Polymorphisms related to lipid metabolism: ApoB, ApoCII, ApoE, ApoAIV
US4943527A (en) * 1985-10-04 1990-07-24 California Biotechnology Inc. Mature apoai protein production under serum free culturing conditions
US5049488A (en) * 1985-11-08 1991-09-17 Genentech, Inc. Method and nucleic acid for the preparation of lecithin:cholesterol acyltransferase
US4973638A (en) * 1986-04-30 1990-11-27 Southwest Foundation For Biomedical Researche Polyamide resin and method for preparation of reagents for immunodiagnostic use
US4962091A (en) * 1986-05-23 1990-10-09 Syntex (U.S.A.) Inc. Controlled release of macromolecular polypeptides
US4792621A (en) * 1986-07-28 1988-12-20 Amoco Corporation Method for continuous production of aromatic carboxylic acid
US4948723A (en) * 1987-01-16 1990-08-14 Bioscience International, Inc. Method of diagnosis and severity-assessment of pancreatic disease
US4828986A (en) * 1986-09-29 1989-05-09 Scripps Clinic And Research Foundation Assay method and diagnostic system for determining the ratio of APO B-100 to APO A-I in a blood sample
DE3636851A1 (de) * 1986-10-29 1988-05-11 Boehringer Mannheim Gmbh Verfahren und reagenz zur spezifischen bestimmung des cholesterins der hdl-fraktion
JPH0667948B2 (ja) * 1986-12-23 1994-08-31 花王株式会社 抗生物質ｙｉ−ｈｕ３及びその製造法
US4935363A (en) * 1987-03-30 1990-06-19 Board Of Regents, The University Of Texas System Sterol regulatory elements
US5032511A (en) * 1987-03-31 1991-07-16 Mitsubishi Kasei Corporation DNA fragments coding for antigens specific to non-A non-B hepatitis, expression vectors containing said DNA fragments, transformants and process for producing said antigens
GB8712540D0 (en) * 1987-05-28 1987-07-01 Ucb Sa Expression of human proapolipoprotein a-i
US4943522A (en) * 1987-06-01 1990-07-24 Quidel Lateral flow, non-bibulous membrane assay protocols
US4892814A (en) * 1987-06-22 1990-01-09 The United States Of America As Represented By The Department Of Health And Human Services Method for distinguishing Creutzfeldt-Jakob disease from other dementias
GB8717791D0 (en) * 1987-07-28 1987-09-03 Baralle F E Immunoassay method
US5055396A (en) * 1987-11-03 1991-10-08 Scripps Clinic And Research Foundation Diagnostic methods and systems for quantifying apo ai
CA1335077C (en) * 1988-02-08 1995-04-04 Henri Isliker Process for the manufacture of apolipoproteins from human blood plasma or serum
US4945040A (en) * 1988-02-29 1990-07-31 Arch Development Corporation Immunoassay for lipoprotein(a)
US5030722A (en) * 1988-03-30 1991-07-09 The Johns Hopkins University Odorant-binding protein from rat
AU4511189A (en) * 1988-10-25 1990-05-14 Invitron Corporation Specific removal of ldl from blood
US4975528A (en) * 1989-04-07 1990-12-04 Affinity Biotech, Inc. Process for separation and concentration of apolipoproteins using perfluorocarbon emulsion
US4920115A (en) * 1988-12-28 1990-04-24 Virginia Commonwealth University Method of lowering LDL cholesterol in blood
US5045480A (en) * 1989-02-09 1991-09-03 Miles Inc. Gel particles having hapten moieties bound thereto as immunoassay reagent
SE8901127D0 (sv) * 1989-03-31 1989-03-31 Aa H L Pousette Reagenssats och dess anvaending foer att bilda (spap-anti-spap) -immunkomplex samt diagnostiskt foerfarand vid vilket spap detekteras
US5187068A (en) * 1989-06-09 1993-02-16 Nicolae Luca Method for determination of lipid moiety and apolipoprotein expressed epitope immunoreactivity on intact lipoprotein

Also Published As

Publication number Publication date
AU9116991A (en) 1992-07-08
DE69115926D1 (de) 1996-02-08
ES2083152T3 (es) 1996-04-01
EP0559795A1 (en) 1993-09-15
ATE132269T1 (de) 1996-01-15
JPH06503418A (ja) 1994-04-14
DE69115926T2 (de) 1996-05-30
AU667462B2 (en) 1996-03-28
US5364793A (en) 1994-11-15
US5583201A (en) 1996-12-10
WO1992010760A1 (en) 1992-06-25
GR3018546T3 (en) 1996-03-31
EP0559795B1 (en) 1995-12-27
CA2097426A1 (en) 1992-05-31

Similar Documents

Publication Publication Date Title
DK0559795T3 (da) Fremgangsmåder til diagnosticering af kroniske smerter i lænderegionen og halshvrivelsøjlen
Jackson et al. The demonstration of new human brain-specific proteins by high-resolution two-dimensional polyacrylamide gel electrophoresis
NO904001D0 (no) Fremgangsmaate og anordning for amperometrisk diagnoseanalyse.
Osserman et al. Abnormal serum and urine proteins in thirty-five cases of multiple myeloma, as studied by filter paper electrophoresis
Hoffman Allergens in bee venom: III. Identification of allergen B of bee venom as an acid phosphatase
ATE348843T1 (de) Nachweis von tsh-rezeptor-autoantikörpern mit affinitätsgereinigten antikörpern
ATE353974T1 (de) Verfahren, zusammensetzungen und kits zur identifizierung und überwachung von brustkrebs
EP1102988B8 (de) Verfahren zur bestimmung der immunabwehraktivität des blutes sowie testkit hierfür
AU7260496A (en) A method and diagnostic test kit for use in aiding the diagnosis of fibromyyalgia and chronic fatigue syndrome (CFS)
DE68928728D1 (de) Diagnose von retinoblastoma
ATE70280T1 (de) Charakteristische polypeptide und antikoerper vom papillomavirus, diagnostische verfahren und dieselben verwendende impfungen.
ATE191976T1 (de) Verfahren zum nachweis von knochen- und anderen bindegewebeerkrankungen in menschen und tieren
ES8501630A1 (es) Un metodo para detectar o vigilar el estado de una condicion patologica humana que implica proteina de tejido conjuntivo.
Lanz et al. Capillary zone electrophoresis with a dynamic double coating for analysis of carbohydrate‐deficient transferrin in human serum: Impact of resolution between disialo‐and trisialotransferrin on reference limits
DE69204157D1 (de) Verfahren zur bestimmung von anti-rns-antikörpern.
ES2067024T3 (es) Metodo y kit para determinar actividades fosforilantes y desfosforilantes de tirosina.
DK0764273T3 (da) Alfa B crystallin til anvendelse i diagnose og terapi af autoimmune sygdomme, især multipel sklerose
ATE196688T1 (de) Verfahren zur vorhersage der therapeutischen antwort eines medikamentes auf einen malignen tumoren
DE69132144D1 (de) Menschliche phospholipase aktivierender proteinteil
DE59209888D1 (de) Monoklonale antikörper gegen das humane tnf-bindende protein i (tnf-bp i)
ATE273517T1 (de) Diagnostische methode zum nachweis von isoformen des eosinophilen kationischen proteins
Cameron et al. Methods for the diagnosis of peripheral nerve damage
YASUDA et al. Analysis of tissue creatine phosphokinase isoenzymes by histoelectrophoresis
Milne et al. Gamma-glutamyl transpeptidase and its multiple forms in the tissues and sera of normal dogs
Eaton SEROLOGICAL STUDIES OF AN ANTIGEN FOUND IN THE PERIPHERAL NERVOUS SYSTEM.